QFQiang Feng

Qiang Feng

*This is an algorithmically generated author record based on publicly available information.

Qiang Feng has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Chuanyuan Kang

    Department of Psychosomatic Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China

    1 shared publication
  • Fanqin Lv

    Department of Cardiology Daqing Fifth Hospital Daqing China

    1 shared publication
  • Fu Meng

    Department of Psychosomatic Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China

    1 shared publication
  • Hao Tang

    Zhengzhou Key Laboratory of Cardiovascular Aging Henan Key Laboratory of Chronic Disease Management National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine Central China Fuwai Hospital of Zhengzhou University Fuwai Central China Cardiovascular Hospital & Central China Subcenter of National Center for Cardiovascular Diseases Zhengzhou Henan China

    1 shared publication
  • Jianzhong Yang

    Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; The Zhejiang Key Laboratory of Precision Psychiatry, Hangzhou 310003, China

    1 shared publication
  • Jing Yuan

    Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Long non‐coding RNA MALAT1 and its target microRNA‐125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease

    by Fanqin Lv, Liang Liu, Qiang Feng, Xuefeng Yang

    Background: This study aimed to explore the correlation of long non‐coding RNA metastasis‐associated lung adenocarcinoma transcript 1 (lncRNA MALAT1) with microRNA (miR)‐125b and further investigated their associations with disease risk, severity, and prognosis of coronary heart disease (CHD).Methods: Totally, 230 patients who underwent diagnostic coronary angiography were recruited; meanwhile, 140 of them were diagnosed as CHD and the remaining 90 non‐CHD patients served as controls. Plasma sample was collected from each participant for lncRNA MALAT1 and miR‐125b mRNA expression detection by reverse transcription‐quantitative polymerase chain reaction. The extent of coronary stenosis was evaluated by the Gensini score, and major adverse cardiovascular event (MACE) occurrence during the follow‐up was documented in CHD patients.Results: Long non‐coding RNA metastasis‐associated lung adenocarcinoma transcript 1 relative expression was increased, but miR‐125b relative expression was decreased in CHD patients compared with controls. ROC curve exhibited that lncRNA MALAT1 and miR‐125b were of good value in differentiating CHD patients from controls, and further logistic regression analysis verified their independent correlation with CHD risk. Furthermore, lncRNA MALAT1 presented a closely negative correlation with miR‐125b in CHD patients, while it presented a weakly negative association with miR‐125b in controls. In CHD patients, lncRNA MALAT1 was positively correlated with Gensini score, total cholesterol, low‐density lipoprotein cholesterol, C‐reactive protein, tumor necrosis factor α, interleukin (IL)‐1β, IL‐6, IL‐17, and accumulating MACE occurrence; reversely, miR‐125b presented a opposite trend.Conclusion: Long non‐coding RNA metastasis‐associated lung adenocarcinoma transcript 1 might be associated with increased CHD risk, severity, and accumulating MACE incidence via negative interaction with miR‐125b, suggesting their possible clinical application as biomarkers in the CHD screening and surveillance.


  • Open Access

    Implementation of quarantine in China during the outbreak of COVID-19

    by Chuanyuan Kang, Fu Meng, Qiang Feng, Jing Yuan, Liang Liu, Li Xu, Shuran Yang, Yujun Wei, Xudong Zhao, Jianzhong Yang


  • Increasing the culture efficiency of hybridoma cells by the use of integrated metabolic control of glucose and glutamine at low levels

    by Ling Li, Li Mi, Qiang Feng, Rong Liu, Hao Tang, Li Xie, Xiaoling Yu, Zhinan Chen

    The metabolism of HAb18 hybridoma cells was shifted to decrease metabolite accumulation and to improve culture efficiency by integrated metabolic control of glucose and glutamine at low levels. When glucose and glutamine levels were decreased to 0.5 and 0.3 mM respectively, lactate and ammonia production were reduced by 62.6 and 74% respectively, glucose‐to‐cell yield was increased from 0.23×109 to 0.66×109 cells·mmol−1, and glutamine‐to‐cell yield from 0.18×109 to 1.95×109 cells·mmol−1. Compared with high‐level glucose and glutamine fed‐batch cultures, low‐level glucose and glutamine led to higher cell density (1.0×107 versus 0.3×107 cells·ml−1), longer culture span (14 as opposed to 8 days) and higher antibody yield (250 as against 150 mg·l−1). These results indicate that hybridoma culture efficiency would be increased by the integrated control of glucose and glutamine at 0.5 and 0.3 mM respectively. In contrast with previously reported glucose‐and/or‐glutamine‐level‐controlled fed‐batch cultures, we demonstrated an efficient strategy of nutrient level selection and amino acid feeding. More importantly, our accurately and well‐distributed Equable Feeding Control System opens a new avenue for reducing metabolites to low levels by controlling nutrients at low levels.